DASTF - Simulation Plus: One-Of-A-Kind Bioinformatics Co. With A 20% 3-Year CAGR
Graphic Source: Simulation Plus, Inc.
Introduction: What is Simulation Plus, Inc?
Simulation Plus, Inc. (NASDAQ: SLP) is a bioinformatics software company focused on advanced modeling and simulations with predictive capabilities for drug discovery assistance and development. Founded in 1996, SLP has 133 employees across various US offices in CA, NY, and NC and a foreign office in Paris, France.
Their main products include: 1) a modeling and simulation platform for drug R&D, 2) predictive software for chemical formulations, 3) analytical software for specific biological and disease states, 4) cloud-based web app for drug-dev and